Humacyte Receives 2021 Life Sciences Award from Triangle Business Journal
May 26, 2021 07:30 ET
|
Humacyte, Inc.
DURHAM, N.C., May 26, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
Humacyte Announces Presentation by Principal Investigator Highlighting Clinical Experience with HAVs at Vascular Access Society of the Americas 2021 Spring Conference
May 22, 2021 15:50 ET
|
Humacyte, Inc.
DURHAM, N.C., May 22, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
Humacyte Presents Advances in Whole-Lung Engineering
May 21, 2021 07:30 ET
|
Humacyte, Inc.
Laboratory and pre-clinical models of whole-lung engineering inform roadmap for building a functional lung alveolus, which is the key building block for making a functional lungData presented at 38th...
Humacyte Appoints Dale Sander as Chief Financial Officer
May 19, 2021 16:30 ET
|
Humacyte, Inc.
DURHAM, N.C., May 19, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
Humacyte Leadership and Investigators to Present at Five Scientific Events in May
May 06, 2021 07:30 ET
|
Humacyte, Inc.
DURHAM, N.C., May 06, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
Humacyte Announces Positive Long-Term Follow-Up Data from Phase 2 Vascular Access Trial
April 21, 2021 08:00 ET
|
Humacyte, Inc.
Five-year outcomes demonstrate HAV retained durability and structural integrity, potentially offering a safe and viable option for long-term hemodialysisLong-term explant samples demonstrate...
Humacyte Secures $50 Million Debt Facility with Silicon Valley Bank
April 14, 2021 07:30 ET
|
Humacyte, Inc.
DURHAM, N.C., April 14, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
Humacyte CEO Dr. Laura Niklason and Alpha Healthcare CEO Rajiv Shukla to Present at CED Venture Connect 2021 Online Summit
March 23, 2021 07:30 ET
|
Humacyte, Inc.
DURHAM, N.C., March 23, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
Humacyte to Present at Oppenheimer 31st Annual Healthcare Conference
March 11, 2021 07:30 ET
|
Humacyte, Inc.
DURHAM, N.C., March 11, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
Humacyte to Present Long-Term Follow-Up Data from Phase 2 Vascular Access Trial at Charing Cross (CX) International Symposium 2021
March 05, 2021 07:30 ET
|
Humacyte, Inc.
DURHAM, N.C., March 05, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...